Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dupilumab
Related studies linked through entity extraction aliases.
Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- Status
- COMPLETED
- Phase
- PHASE2
Cholinergic Urticaria - Efficacy of Dupilumab
- Status
- COMPLETED
- Phase
- PHASE2
Dupilumab in Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Investigating Dupilumab's Effect in Asthma by Genotype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab for Aspirin-exacerbated Respiratory Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dupilumab Phase 4 Study
- Status
- TERMINATED
- Phase
- N/A
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE4
Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2